메뉴 건너뛰기
Diabetes Care
Volumn 36, Issue 7, 2013, Pages
Relationship of sex to diabetes risk in statin trials
Author keywords

[No Author keywords available]
Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PLACEBO; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN;
EID: 84886072892     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc13-0490     Document Type: Letter
Times cited : (26)
References (6)
  • 1
    • 0035936527 scopus 로고    scopus 로고
    • Pravastatin and the development of diabetes mellitus: Evidence for a protective treatment effect in theWest of Scotland Coronary Prevention Study
    • Freeman DJ, Norrie J, Sattar N, et al. Pravastatin and the development of diabetes mellitus: evidence for a protective treatment effect in theWest of Scotland Coronary Prevention Study. Circulation 2001;103:357-362
    • (2001) Circulation , vol.103 , pp. 357-362
    • Freeman, D.J.1    Norrie, J.2    Sattar, N.3
  • 2
    • 56749106312 scopus 로고    scopus 로고
    • JUPITER study group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein
    • Ridker PM, Danielson E, Fonseca FA, et al.; JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008;359:2195-2207
    • (2008) N Engl J Med , vol.359 , pp. 2195-2207
    • Ridker, P.M.1    Danielson, E.2    Fonseca, F.A.3
  • 3
    • 77549087054 scopus 로고    scopus 로고
    • Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials
    • Sattar N, Preiss D,Murray HM, et al. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials. Lancet 2010;375:735-742
    • (2010) Lancet , vol.375 , pp. 735-742
    • Sattar, N.1    Preiss, D.2    Murray, H.M.3
  • 4
    • 77949397716 scopus 로고    scopus 로고
    • Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: Results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) andmeta-analysis of women from primary prevention trials
    • Mora S, Glynn RJ, Hsia J, MacFadyen JG, Genest J, Ridker PM. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) andmeta-analysis of women from primary prevention trials. Circulation 2010;121:1069-1077
    • (2010) Circulation , vol.121 , pp. 1069-1077
    • Mora, S.1    Glynn, R.J.2    Hsia, J.3    Macfadyen, J.G.4    Genest, J.5    Ridker, P.M.6
  • 5
    • 84862908066 scopus 로고    scopus 로고
    • Statin use and risk of diabetes mellitus in postmenopausal women in the Women's health initiative
    • Culver AL, Ockene IS, Balasubramanian R, et al. Statin use and risk of diabetes mellitus in postmenopausal women in the Women's Health Initiative. Arch Intern Med 2012; 172:144-152
    • (2012) Arch Intern Med , vol.172 , pp. 144-152
    • Culver, A.L.1    Ockene, I.S.2    Balasubramanian, R.3
  • 6
    • 79953183649 scopus 로고    scopus 로고
    • Predictors of new-onset diabetes in patients treated with atorvastatin: Results from 3 large randomized clinical trials
    • Waters DD, Ho JE, DeMicco DA, et al. Predictors of new-onset diabetes in patients treated with atorvastatin: results from 3 large randomized clinical trials. J Am Coll Cardiol 2011;57:1535-1545
    • (2011) J Am Coll Cardiol , vol.57 , pp. 1535-1545
    • Waters, D.D.1    Ho, J.E.2    Demicco, D.A.3

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.